Richard G. Ghalie - Jul 5, 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Chief Medical Officer
Signature
/s/ Brian G. Drazba, as attorney in fact
Stock symbol
MEIP
Transactions as of
Jul 5, 2022
Transactions value $
-$4,426
Form type
4
Date filed
7/7/2022, 04:17 PM
Previous filing
Jul 6, 2021
Next filing
Oct 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEIP Common Stock Tax liability -$4.43K -8.2K -22.08% $0.54* 28.9K Jul 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +560K $0.00 560K Jul 5, 2022 Common Stock 560K $0.54 Direct F2
holding MEIP Stock Option (Right to Buy) 320K Jul 5, 2022 Common Stock 320K $2.95 Direct F3
holding MEIP Stock Option (Right to Buy) 130K Jul 5, 2022 Common Stock 130K $1.21 Direct F4
holding MEIP Stock Option (Right to Buy) 25K Jul 5, 2022 Common Stock 25K $1.38 Direct F4
holding MEIP Stock Option (Right to Buy) 65K Jul 5, 2022 Common Stock 65K $2.88 Direct F4
holding MEIP Stock Option (Right to Buy) 130K Jul 5, 2022 Common Stock 130K $4.28 Direct F5
holding MEIP Stock Option (Right to Buy) 150K Jul 5, 2022 Common Stock 150K $2.52 Direct F6
holding MEIP Stock Option (Right to Buy) 150K Jul 5, 2022 Common Stock 150K $3.49 Direct F7
holding MEIP Stock Option (Right to Buy) 75K Jul 5, 2022 Common Stock 75K $3.55 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
F2 One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
F3 One-quarter of such options vested on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
F4 All options are currently exercisable.
F5 One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
F6 One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
F7 One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
F8 One-quarter of such options vested on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.